Last reviewed · How we verify

NCT04974489

Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes

Completed NA Results posted Last updated 8 November 2022
What this trial tests

NA trial testing Emotion-based messages about the harm of VLNC in Tobacco Use, Cigarette Use in 1,153 participants. Completed in 3 August 2021.

Timeline
1 July 2021
Primary endpoint
3 August 2021
3 August 2021

Quick facts

Lead sponsorUNC Lineberger Comprehensive Cancer Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment1,153
Start date1 July 2021
Primary completion3 August 2021
Estimated completion3 August 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

UNC Lineberger Comprehensive Cancer Center — full company profile →

Who can join

18 and older, any sex, with Tobacco Use, Cigarette Use. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Very Low Nicotine Content (VLNC) Misperception Primary · During one day survey

Measured by a 3 item scale. Very low nicotine content (VLNC) Misperception measured with 3 questions, the final VLNC misperception score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more harmful than other cigarettes, and 5 indicates a perception that VLNC are much less harmful than other cigarettes, and 3 is a perception that VLNC are as harmful as other cigarettes.

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC3.12± 0.56
Continued-harm-framed Messages About the Harm of VLNC3.04± 0.61
Myth-refuting Messages About the Harm of VLNC3.04± 0.54
Control Messages About Littering3.36± 0.80
Quit Intentions Secondary · During one day survey

Measured by a 3 item scale. Quit intention measured with 3 questions, the final quit intention score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low intention to quit smoking, and 5 indicates a high intention to quit.

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC2.88± 1.22
Continued-harm-framed Messages About the Harm of VLNC2.80± 1.13
Myth-refuting Messages About the Harm of VLNC2.87± 1.27
Control Messages About Littering2.85± 1.26
Perceived Message Effectiveness Secondary · During one day survey

Measured by a 3 item scale after each message, 9 items total. Perceived message effectiveness measured with 3 questions per message. The final perceived message effectiveness score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low perceived message effectiveness, and 5 indicates high perceived message effectiveness.

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC3.07± 0.87
Continued-harm-framed Messages About the Harm of VLNC3.26± 0.86
Myth-refuting Messages About the Harm of VLNC3.17± 0.90
Control Messages About Littering2.45± 0.96
Perceived Understandability Secondary · During one day survey

Perceived Understandability is measured with 1 question on a scale of 1 to 5: "How easy was it to understand the three black and white messages we showed you earlier?", where 1 = "Not at all", 5 = "Very", and 3 = "Somewhat"

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC4.48± 0.82
Continued-harm-framed Messages About the Harm of VLNC4.5± 0.83
Myth-refuting Messages About the Harm of VLNC4.37± 0.86
Control Messages About Littering4.35± 0.94
Attention Secondary · During one day survey

Attention is measured with 1 question on a scale of 1 to 5: "How much did the messages grab your attention?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC3.26± 1.22
Continued-harm-framed Messages About the Harm of VLNC2.14± 1.10
Myth-refuting Messages About the Harm of VLNC3.13± 1.16
Control Messages About Littering2.73± 1.12
Negative Affect Secondary · During one day survey

Negative affect is measured with 1 question on a scale of 1 to 5: "How much did the messages make you feel scared?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC2.18± 1.31
Continued-harm-framed Messages About the Harm of VLNC1.97± 1.15
Myth-refuting Messages About the Harm of VLNC1.93± 1.13
Control Messages About Littering1.42± 0.78
Cognitive Reactions Secondary · During one day survey

Cognitive Reactions are measured with 1 question on a scale of 1 to 5: "How much did the messages make you think about the risk of smoking cigarettes that have 95% less nicotine?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC2.68± 1.29
Continued-harm-framed Messages About the Harm of VLNC2.68± 1.28
Myth-refuting Messages About the Harm of VLNC2.66± 1.23
Control Messages About Littering1.97± 1.11
Social Interactions Secondary · During one day survey

Social Interactions are measured with 1 question on a scale of 1 to 5: "How much would you talk with other people about the messages?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC2.28± 1.28
Continued-harm-framed Messages About the Harm of VLNC2.16± 1.16
Myth-refuting Messages About the Harm of VLNC2.24± 1.17
Control Messages About Littering2.09± 1.17
Reactance Secondary · During one day survey

Reactance is measured with 1 question on a scale of 1 to 5: "How much do you feel that the messages are trying to manipulate you?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC2.81± 1.41
Continued-harm-framed Messages About the Harm of VLNC2.61± 1.40
Myth-refuting Messages About the Harm of VLNC2.62± 1.36
Control Messages About Littering2.44± 1.33
Interest in Other Nicotine Products Secondary · During one day survey

Measured by a 3 item scale. Interest in other nicotine products with 3 questions, the final score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low interest in other nicotine products, and 5 indicates a high interest in other nicotine products.

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC2.75± 0.86
Continued-harm-framed Messages About the Harm of VLNC2.80± 0.78
Myth-refuting Messages About the Harm of VLNC2.77± 0.85
Control Messages About Littering2.66± 0.84
Percentage of Participants With Very Low Nicotine Content (VLNC) Misperception About Harm (Dichotomized) Primary · During one day survey

Very low nicotine content (VLNC) Misperception of Harm was measured with 1 question, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more harmful than other cigarettes, and 5 indicates a perception that VLNC are much less harmful than other cigarettes, and 3 is a perception that VLNC are as harmful as other cigarettes. The results were dichotomized to indicate the percentage of people who hold the misperception. Specifically, responses of "much less likely" (5) or "less likely" (4) were recoded as 1 (having the misperception), and responses of "Much more likely" (1), "M

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC18.313.6 – 23.0
Continued-harm-framed Messages About the Harm of VLNC12.68.6 – 16.7
Myth-refuting Messages About the Harm of VLNC11.47.5 – 15.3
Control Messages About Littering38.232.3 – 44.1
Percentage of Participants With Very Low Nicotine Content (VLNC) Misperception About Cancer (Dichotomized) Primary · During one day survey

Very low nicotine content (VLNC) Misperception of Risk of Cancer was measured with 1 question, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more likely to cause cancer than other cigarettes, and 5 indicates a perception that VLNC are much less likely to cause cancer than other cigarettes, and 3 is a perception that VLNC are as likely to cause cancer as other cigarettes. The results were dichotomized to indicate the percentage of people who hold the misperception. Specifically, responses of "much less likely" (5) or "less likely" (4) were recoded as 1 (having the misp

GroupValue95% CI
Emotion-based Messages About the Harm of VLNC16.812.2 – 21.4
Continued-harm-framed Messages About the Harm of VLNC11.17.3 – 14.9
Myth-refuting Messages About the Harm of VLNC9.55.9 – 13.1
Control Messages About Littering31.826.2 – 37.5

Sponsor's own description

Tobacco use is the leading preventable cause of cancer and cancer deaths in the US. While most (69%) smokers want to quit, only 6% succeed in doing so each year. For many smokers, the addictiveness of nicotine makes quitting very difficult. To reduce cigarette smoking and resulting harms, FDA has announced a comprehensive approach to tobacco and nicotine regulation that includes moving toward a very low nicotine content (VLNC) standard for cigarettes. Greatly reduced nicotine levels would facilitate smoking cessation. However, the maximal success of the policy may require public understanding that, although these new cigarettes are less addictive, their high toxicity and carcinogenicity are unchanged. Yet, nearly half of adult smokers incorrectly think smoking VLNC cigarettes is less harmful than smoking current cigarettes (the VLNC misperception). Additionally, 24% of smokers said they would be less likely to quit if a VLNC regulation is enacted. Thus, the VLNC misperception may partially undermine a nicotine reduction policy. Although communication research suggests it is challenging to change people's incorrect understanding, new communication techniques may help reduce the VLNC misperception. In this randomized trial we will examine whether messages about the harm of VLNC cigarettes can reduce the VLNC misperception and increase intention to quit in a nicotine reduction scenario.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other UNC Lineberger Comprehensive Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04974489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing